Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yerong Yu

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Advances in Therapy|July 9, 2026
Pharmacokinetics, Pharmacodynamics, and Safety of Once-Weekly Insulin Efsitora Alfa in Chinese Patients with Type 2 Diabetes: A Phase 1 Open-Label, Randomized, Active-Controlled TrialHui Liu, Yuxin Fan, Yihui Wang, et al.
Diabetes Research and Clinical Practice|November 6, 2010
Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patientsChun Wang, Huiwen Tan, Hongling Yu, et al.
Frontiers in Endocrinology|November 11, 2021
Spontaneous Remission After a Hypercalcemic Crisis Caused by an Intracystic Hemorrhage of Bilateral Parathyroid Adenomas: A Case Report and Literature ReviewYaoxia Liu, Jianwei Li, Hui Liu, et al.
Expert Opinion on Investigational Drugs|September 4, 2023
A phase-I randomized euglycemic clamp study to demonstrate the pharmacokinetic and pharmacodynamic equivalence of an insulin degludec biosimilar (B01411) with the reference product in healthy Chinese volunteersHui Liu, Ting Li, Hongling Yu, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|December 17, 2004
[Pioglitazone hydrochloride monotherapy or in combination with sulfonylurea therapy improves glycemia control in patients with type 2 diabetes]Yerong Yu, Yanbing Li, Jiyuan Fan, et al.
Scientific Reports|August 6, 2021
Author Correction: Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese malesHui Liu, Hongling Yu, Lisi Sun, et al.
Scientific Reports|May 5, 2021
Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese malesHui Liu, Hongling Yu, Lisi Sun, et al.
Clinical Pharmacology in Drug Development|August 19, 2021
A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese SubjectsHui Liu, Feng Wang, Yongjia Ji, et al.
BMC Endocrine Disorders|August 2, 2020
Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case reportHuiwen Tan, Dawei Chen, Yerong Yu, et al.
Endocrine|August 25, 2021
Elevated thyroid-stimulating hormone levels are associated with poor sleep: a cross-sectional and longitudinal studyYuerong Yan, Jiaqi Li, Huairong Tang, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Advances in Therapy|July 9, 2026
Pharmacokinetics, Pharmacodynamics, and Safety of Once-Weekly Insulin Efsitora Alfa in Chinese Patients with Type 2 Diabetes: A Phase 1 Open-Label, Randomized, Active-Controlled TrialHui Liu, Yuxin Fan, Yihui Wang, et al.
Diabetes Research and Clinical Practice|November 6, 2010
Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patientsChun Wang, Huiwen Tan, Hongling Yu, et al.
Frontiers in Endocrinology|November 11, 2021
Spontaneous Remission After a Hypercalcemic Crisis Caused by an Intracystic Hemorrhage of Bilateral Parathyroid Adenomas: A Case Report and Literature ReviewYaoxia Liu, Jianwei Li, Hui Liu, et al.
Expert Opinion on Investigational Drugs|September 4, 2023
A phase-I randomized euglycemic clamp study to demonstrate the pharmacokinetic and pharmacodynamic equivalence of an insulin degludec biosimilar (B01411) with the reference product in healthy Chinese volunteersHui Liu, Ting Li, Hongling Yu, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|December 17, 2004
[Pioglitazone hydrochloride monotherapy or in combination with sulfonylurea therapy improves glycemia control in patients with type 2 diabetes]Yerong Yu, Yanbing Li, Jiyuan Fan, et al.
Scientific Reports|August 6, 2021
Author Correction: Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese malesHui Liu, Hongling Yu, Lisi Sun, et al.
Scientific Reports|May 5, 2021
Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese malesHui Liu, Hongling Yu, Lisi Sun, et al.
Clinical Pharmacology in Drug Development|August 19, 2021
A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese SubjectsHui Liu, Feng Wang, Yongjia Ji, et al.
BMC Endocrine Disorders|August 2, 2020
Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case reportHuiwen Tan, Dawei Chen, Yerong Yu, et al.
Endocrine|August 25, 2021
Elevated thyroid-stimulating hormone levels are associated with poor sleep: a cross-sectional and longitudinal studyYuerong Yan, Jiaqi Li, Huairong Tang, et al.
Pageof 8